Morgan Stanley analyst Erin Wright downgraded Heska to Underweight from Equal Weight with a $58 price target.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on HSKA:
- Dalan Animal Health granted USDA conditional license for honeybee vaccine
- Heska price target lowered to $165 from $170 at Piper Sandler
- Heska price target lowered to $119 from $155 at Alliance Global Partners
- Heska sees FY22 revenue in line with FY22 and up 5%
- Heska reports Q4 non-GAAP EPS 41c, consensus (11c)